BioVentures Investors

Investor type

PE / VC

Founded

1998

AUM

$200 M

Location

Boston, Massachusetts, United States

$10-50 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series A, Series B, Late Stage (Series C+)

Investment Stage

Acquisition

Exit Strategy

Investor profile last updated: 27 July, 2026

Profile

ADVANCING THE GROWTH OF MEDTECH:
We are partner with the innovators who are changing the practice of medicine. BioVentures MedTech Funds invests in companies that are developing today's leading-edge biomedical technologies. Together, we create dynamic solutions that improve health outcomes and reduce the cost of care.

Industry

Biotechnology Healthcare Services Medical Devices Software MedTech Life Sciences Infrastructure HealthTech Digital

Region of investment

North America

BioVentures Investors Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
BioVentures Investors IV, LP
Venture Capital (VC)
Biotechnology
Digital
Healthcare Services
Medical Devices
HealthTech
Pre-seed
Seed
North America
$5-10 m
$87 M
October 2016

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
3BGTq7YOnxUXpyem 3BGTq7YOnxUXpyem
3BGTq7YOnxUXpyem
avatar
3BGTq7YOnxUXpyem 3BGTq7YOnxUXpyem
3BGTq7YOnxUXpyem
avatar
3BGTq7YOnxUXpyem 3BGTq7YOnxUXpyem
3BGTq7YOnxUXpyem
avatar
3BGTq7YOnxUXpyem 3BGTq7YOnxUXpyem
3BGTq7YOnxUXpyem
avatar
3BGTq7YOnxUXpyem 3BGTq7YOnxUXpyem
3BGTq7YOnxUXpyem
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about BioVentures Investors

BioVentures Investors is located in Boston, Massachusetts, United States.
BioVentures Investors was founded in 1998.
BioVentures Investors invests in companies and startups in Biotechnology, Healthcare Services, Medical Devices, Software, MedTech, Life Sciences, Infrastructure, HealthTech, Digital.
BioVentures Investors invests in companies and startups in North America.
BioVentures Investors invests in companies and startups at Seed, Series A, Series B, Late Stage (Series C+).
BioVentures Investors usually invests $10-50 m on average.
BioVentures Investors has around $200m assets under management.
BioVentures Investors last fund was created/launched in 2016-10-07